Medicines
that Matter
With a vision of creating a healthier tomorrow, we are steadfast in our commitment to deliver first-in-class medicines to patients with unmet medical needs.
10/28/2024 Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting
Disease Areas of Focus
We focus on therapeutic areas where patients continue
to need additional treatment options.
Chronic Kidney Disease with Hyperphosphatemia
Hyperphosphatemia is a serious condition that is estimated to affect the vast majority of patients with chronic kidney disease on dialysis.
Irritable Bowel Syndrome with Constipation
IBS-C is a gastrointestinal disorder characterized by abdominal pain and constipation, and is associated with significantly impaired quality of life.
Commitment to Patients
As a company dedicated to advancing patient care, we believe in working closely with patients and their caregivers, listening to their needs and insights, and setting new standards in product innovation and community engagement.
Learn More
Working at Ardelyx
Grounded in our core values — Fearless, Passionate, Dedicated and Inclusive — we foster a collaborative environment where everyone is heard and feels respected and valued.
Join Us